temozolomide has been researched along with Polyploid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kipper, FC | 1 |
| Silva, AO | 1 |
| Marc, AL | 1 |
| Confortin, G | 1 |
| Junqueira, AV | 1 |
| Neto, EP | 1 |
| Lenz, G | 1 |
| Pérès, EA | 1 |
| Gérault, AN | 1 |
| Valable, S | 1 |
| Roussel, S | 1 |
| Toutain, J | 1 |
| Divoux, D | 1 |
| Guillamo, JS | 1 |
| Sanson, M | 1 |
| Bernaudin, M | 1 |
| Petit, E | 1 |
2 other studies available for temozolomide and Polyploid
| Article | Year |
|---|---|
Vinblastine and antihelmintic mebendazole potentiate temozolomide in resistant gliomas.
Topics: Anthelmintics; Cell Cycle Checkpoints; Cell Line, Tumor; Cellular Senescence; Drug Resistance, Neopl | 2018 |
Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe.
Topics: Animals; Antineoplastic Agents, Alkylating; Blotting, Western; Brain Neoplasms; Cell Cycle Checkpoin | 2015 |